Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Osteoporosis and inflammation.

Gregory R Mundy1

  • 1Vanderbilt Center for Bone Biology, Vanderbilt University Medical Center, Nashville, Tennessee 37232-0575, USA. gregory.r.mundy@vanderbilt.edu

Nutrition Reviews
|February 5, 2008
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The polyphenol resveratrol promotes skeletal growth in mice through a sirtuin 1-bone morphogenic protein 2 longevity axis.

British journal of pharmacology·2018
Same author

Bmp2 in osteoblasts of periosteum and trabecular bone links bone formation to vascularization and mesenchymal stem cells.

Journal of cell science·2013
Same author

Silent information regulator (Sir)T1 inhibits NF-κB signaling to maintain normal skeletal remodeling.

Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research·2012
Same author

Osteoclasts in multiple myeloma are derived from Gr-1+CD11b+myeloid-derived suppressor cells.

PloS one·2012
Same author

Bone-derived IGF mediates crosstalk between bone and breast cancer cells in bony metastases.

Cancer research·2012
Same author

Bone marrow stromal cells create a permissive microenvironment for myeloma development: a new stromal role for Wnt inhibitor Dkk1.

Cancer research·2012
Same journal

Natural Approaches to Appetite Suppression in Obesity: Mechanisms, Evidence, and Clinical Integration.

Nutrition reviews·2026
Same journal

The Effect of Long-Chain Omega-3 Polyunsaturated Fatty Acid Supplementation on Neuromuscular Function in Humans: A Systematic Review with Narrative Synthesis.

Nutrition reviews·2026
Same journal

Oats in Gluten-Free Diets: An Examination of the Codex Standard and Country-Specific Differences in Gluten-Free-Food Labeling Regulations, for Oats and Oats Declared as Ingredients in Gluten-Free Products.

Nutrition reviews·2026
Same journal

Ultra-Processed Foods and Health Outcomes in Children and Adults: An Updated Narrative Umbrella Review With a Focus on Dose-Response.

Nutrition reviews·2026
Same journal

A Scoping Review of Nutritional Guidelines and Practices in Day Care Centers.

Nutrition reviews·2026
Same journal

Time-Restricted Feeding/Eating and Muscle Aging: Research Progress from Molecular Mechanisms to Personalized Intervention Strategies.

Nutrition reviews·2026
See all related articles

Menopause-related estrogen loss accelerates bone loss by increasing pro-inflammatory cytokines and RANKL. Targeting RANKL shows promise for treating osteoporosis and bone metastasis.

Area of Science:

  • Bone Biology and Metabolism
  • Endocrinology
  • Immunology

Background:

  • Osteoporosis affects millions, with estrogen withdrawal during menopause being a key factor.
  • Pro-inflammatory cytokines (IL-1, TNF-α, IL-6) and osteoclastic bone resorption are implicated in menopausal bone loss.
  • Estrogen withdrawal increases pro-inflammatory cytokine production, contributing to bone resorption.

Purpose of the Study:

  • To review the role of pro-inflammatory cytokines and the RANKL/RANK/osteoprotegerin system in post-menopausal osteoporosis.
  • To highlight RANKL as a critical mediator of osteoclastogenesis and a therapeutic target.

Main Methods:

  • Review of human and animal experimental data linking estrogen, cytokines, and bone loss.
  • Discussion of the discovery and function of the RANKL/RANK pathway.

Related Experiment Videos

  • Examination of RANKL expression changes in post-menopausal women.

    • Main Results:

    • Estrogen withdrawal elevates pro-inflammatory cytokines, driving osteoclastic bone resorption.
    • RANKL (Receptor Activator of Nuclear factor Kappa-B Ligand) binding to RANK is crucial for osteoclast differentiation and activation.
    • RANKL expression is higher in post-menopausal women and reduced by estrogen replacement therapy.

    Conclusions:

    • The RANKL/RANK pathway is central to estrogen-regulated bone resorption.
    • Targeting RANKL with specific antibodies is a promising therapeutic strategy for post-menopausal osteoporosis and bone metastases.